Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Ifrah

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Blood Advances|May 24, 2024
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemiaAnne-Charlotte Le Floch, Florence Orlanducci, Marie-Christine Béné, et al.
Blood|September 10, 2015
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantationChristoph Schmid, Myriam Labopin, Gerard Socié, et al.
Clinical Genitourinary Cancer|July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Cancer Immunology Research|January 12, 2020
Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor PhenotypeLéa Paolini, Clément Adam, Céline Beauvillain, et al.
Haematologica|March 30, 2013
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Ambroise Marcais, Raphael Porcher, Marie Robin, et al.
Frontiers in Immunology|June 15, 2017
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid LeukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Blood|August 13, 2011
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL studyRaouf Ben Abdelali, Vahid Asnafi, Thibaut Leguay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 StudyStéphane Lepretre, Aurore Touzart, Thomas Vermeulin, et al.
Cancer Discovery|June 30, 2016
Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell LeukemiaAmélie Trinquand, Nuno R Dos Santos, Christine Tran Quang, et al.
Cancer Cell|April 21, 2012
TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expressionSaïda Dadi, Sandrine Le Noir, Dominique Payet-Bornet, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Blood Advances|May 24, 2024
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemiaAnne-Charlotte Le Floch, Florence Orlanducci, Marie-Christine Béné, et al.
Blood|September 10, 2015
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantationChristoph Schmid, Myriam Labopin, Gerard Socié, et al.
Clinical Genitourinary Cancer|July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Cancer Immunology Research|January 12, 2020
Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor PhenotypeLéa Paolini, Clément Adam, Céline Beauvillain, et al.
Haematologica|March 30, 2013
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Ambroise Marcais, Raphael Porcher, Marie Robin, et al.
Frontiers in Immunology|June 15, 2017
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid LeukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Blood|August 13, 2011
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL studyRaouf Ben Abdelali, Vahid Asnafi, Thibaut Leguay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 StudyStéphane Lepretre, Aurore Touzart, Thomas Vermeulin, et al.
Cancer Discovery|June 30, 2016
Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell LeukemiaAmélie Trinquand, Nuno R Dos Santos, Christine Tran Quang, et al.
Cancer Cell|April 21, 2012
TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expressionSaïda Dadi, Sandrine Le Noir, Dominique Payet-Bornet, et al.
Pageof 17